Medicare Enrolled
Dr. Rajesh Agrawal, MD
Pulmonary Disease · Pinellas Park, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Agrawal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agrawal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Agrawal
Dr. Rajesh Agrawal is a pulmonary disease specialist in Pinellas Park, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Agrawal performed 6,085 Medicare services across 3,092 unique beneficiaries.
Between the years covered by Open Payments, Dr. Agrawal received a total of $207,166 from 54 pharmaceutical and/or device companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Agrawal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in FL
$207,166 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 68290 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗6,085
Medicare services
Top 3% in FL for pulmonary disease
3,092
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~304 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,170 | $95 | $235 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
847 | $96 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
502 | $64 | $158 |
| Inpatient or observation ventilation management Follow-up care for a patient receiving ventilator support during an inpatient stay or observation period. This service involves the ongoing management and adjustment of breathing assistance. |
426 | $52 | $125 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
371 | $103 | $255 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
334 | $64 | $160 |
| Exercise test for lung airway spasm A test performed during physical activity to check for spasms in the lung airways. |
241 | $56 | $145 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
240 | $32 | $85 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
239 | $27 | $75 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
236 | $42 | $105 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
227 | $173 | $535 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
170 | $40 | $100 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
167 | $21 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
158 | $62 | $175 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
103 | $103 | $490 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $119 | $325 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
85 | $137 | $340 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
78 | $85 | $205 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
70 | $59 | $145 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
40 | $218 | $535 |
| Initial hospital inpatient or observation ventilation assistance and management This code covers the initial management and assistance with mechanical ventilation for a patient admitted to the hospital or placed in observation status. |
39 | $74 | $180 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
33 | $95 | $1,200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $11 | $25 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
31 | $50 | $125 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
30 | $94 | $1,120 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 28 | $62 | $160 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
21 | $9 | $20 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $45 | $110 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $67 | $165 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
16 | $107 | $260 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
16 | $41 | $100 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
12 | $27 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$207,166
Total received (2018-2024)
Avg $29,595/year across 7 years
Top 2% in FL for pulmonary disease
54
Companies
971
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$191,502 (92.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,664 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$57,677
2023
$69,139
2022
$23,617
2021
$46,477
2020
$5,782
2019
$2,084
2018
$2,391
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$192,501
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,949
AstraZeneca Pharmaceuticals LP
$1,917
Insmed, Inc.
$1,077
Olympus Corporation of the Americas
$1,020
Paratek Pharmaceuticals, Inc.
$859
Regeneron Healthcare Solutions, Inc.
$764
Harmony Biosciences LLC
$559
Mallinckrodt Hospital Products Inc.
$496
Mylan Specialty L.P.
$472
JAZZ PHARMACEUTICALS INC.
$411
Bayer HealthCare Pharmaceuticals Inc.
$347
United Therapeutics Corporation
$336
Takeda Pharmaceuticals U.S.A., Inc.
$311
Jazz Pharmaceuticals Inc.
$287
Janssen Pharmaceuticals, Inc
$238
Baxter Healthcare
$233
TETRAPHASE PHARMACEUTICALS, INC.
$232
Actelion Pharmaceuticals US, Inc.
$226
Genentech USA, Inc.
$218
HARMONY BIOSCIENCES LLC
$218
Electromed, Inc.
$216
GENZYME CORPORATION
$207
Inogen, Inc.
$171
Sunovion Pharmaceuticals Inc.
$165
Melinta Therapeutics, Inc.
$161
PFIZER INC.
$152
Teva Pharmaceuticals USA, Inc.
$143
La Jolla Pharmaceutical Company
$112
Grifols USA, LLC
$110
Amgen Inc.
$98
Merck Sharp & Dohme LLC
$92
Merck Sharp & Dohme Corporation
$87
Circassia Pharmaceuticals Inc
$81
Vanda Pharmaceuticals Inc.
$78
Melinta Therapeutics, LLC
$76
Novartis Pharmaceuticals Corporation
$57
Cardiovascular Systems Inc.
$53
PORTOLA PHARMACEUTICALS, INC.
$52
Philips North America LLC
$51
Advanced Respiratory, Inc
$47
Hikma Pharmaceuticals USA
$35
Lupin Inc.
$34
ADVANCED RESPIRATORY, INC
$31
IDORSIA PHARMACEUTICALS US INC
$30
INOGEN, INC.
$30
Medtronic, Inc.
$26
Arbor Pharmaceuticals, Inc.
$20
Philips Electronics North America Corporation
$18
Veran Medical Technologies, Inc.
$16
Shire North American Group Inc
$15
Pharming Healthcare, Inc.
$14
Apria Healthcare LLC
$12
Harmony Biosciences Llc
$5
Top 3 companies account for 94.8% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (AE4) Secretion Management · ACTHAR · ADCIRCA · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · CINQAIR · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Diamondback Coronary · ELIQUIS · Esbriet · FASENRA · GIAPREZA · GLASSIA · HETLIOZ · Hillrom - Vest System Model 105 Home Care · Horizant · ILLUMISITE · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · LONHALA MAGNAIR · Medela · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · Orbactiv · PREVNAR - 13 · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · QVAR · RUCONEST · Rezzayo · Ryaltris · SINGLE USE SUCTION VALVE (Sterile) · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SUPRAX · SYMBICORT · Single Use Guide Sheath Kit · Spin · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UTIBRON · Utibron · Vabomere · WAKIX · WINREVAIR · Wakix · XARELTO · XERAVA · XOLAIR · XYREM · XYWAV · Xerava · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in FL.
Equivalent to $3,405 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
88
Per 100K population
9.2
County median income
$70,293
Nearest hospital
HCA FLORIDA NORTHSIDE HOSPITAL
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Agrawal is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), with speaking/promotional industry engagement in the top 2% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Agrawal experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Agrawal performed 1,170 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agrawal receive payments from pharmaceutical companies?
Yes. Dr. Agrawal received a total of $207,166 from 54 companies across 971 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agrawal's costs compare to other pulmonary diseases in Pinellas Park?
Dr. Agrawal's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agrawal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Pinellas Park
Browse pulmonary diseases in Pinellas Park ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology